# Coherus Oncology, Inc.: Form 8-K, filed Mar 10, 2025

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: 8-K
- Filed: 2025-03-10
- Accepted by EDGAR: Mar 10, 2025, 16:31 ET
- Period: 2025-03-10
- Accession: 0001558370-25-002595
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000155837025002595/chrs-20250310x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000155837025002595/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000155837025002595/chrs-20250310x8k.htm

Filed Mar 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-002595. Last ingested by Listed: Oct 29, 2026, 08:11 ET. No prices; not investment advice.